Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 20% ± 6% | |
epithelial cell | 3 studies | 27% ± 9% |
Insufficient scRNA-seq data for expression of TRIM5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1099.71 | 1445 / 1445 | 99% | 11.47 | 182 / 183 |
thymus | 100% | 1829.66 | 653 / 653 | 99% | 16.57 | 601 / 605 |
lung | 100% | 2001.82 | 578 / 578 | 99% | 14.03 | 1145 / 1155 |
ovary | 100% | 1724.13 | 180 / 180 | 99% | 11.24 | 425 / 430 |
intestine | 100% | 1206.80 | 966 / 966 | 99% | 11.11 | 520 / 527 |
stomach | 100% | 995.21 | 359 / 359 | 99% | 10.97 | 282 / 286 |
prostate | 100% | 1604.81 | 245 / 245 | 98% | 15.11 | 494 / 502 |
bladder | 100% | 1277.86 | 21 / 21 | 98% | 12.99 | 495 / 504 |
kidney | 100% | 1225.19 | 89 / 89 | 98% | 15.18 | 879 / 901 |
breast | 100% | 1236.43 | 459 / 459 | 97% | 13.24 | 1089 / 1118 |
uterus | 100% | 1844.94 | 170 / 170 | 97% | 13.17 | 446 / 459 |
pancreas | 100% | 1543.25 | 328 / 328 | 97% | 11.74 | 172 / 178 |
liver | 100% | 1394.27 | 226 / 226 | 96% | 10.59 | 391 / 406 |
skin | 100% | 1184.99 | 1806 / 1809 | 94% | 12.54 | 445 / 472 |
adrenal gland | 100% | 1826.73 | 258 / 258 | 57% | 4.09 | 130 / 230 |
brain | 43% | 157.72 | 1127 / 2642 | 86% | 8.74 | 606 / 705 |
adipose | 100% | 1262.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.42 | 29 / 29 |
spleen | 100% | 2007.05 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.91 | 1 / 1 |
blood vessel | 100% | 1578.17 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 655.33 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1763.99 | 913 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 10.59 | 41 / 45 |
eye | 0% | 0 | 0 / 0 | 83% | 6.13 | 66 / 80 |
muscle | 32% | 99.15 | 260 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0051607 | Biological process | defense response to virus |
GO_0032880 | Biological process | regulation of protein localization |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0046597 | Biological process | negative regulation of viral entry into host cell |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0002218 | Biological process | activation of innate immune response |
GO_0006914 | Biological process | autophagy |
GO_0031664 | Biological process | regulation of lipopolysaccharide-mediated signaling pathway |
GO_0044790 | Biological process | suppression of viral release by host |
GO_0046596 | Biological process | regulation of viral entry into host cell |
GO_1990462 | Cellular component | omegasome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0038187 | Molecular function | pattern recognition receptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TRIM5 |
Protein name | Tripartite motif-containing protein 5 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM5) Tripartite motif-containing protein 5 (EC 2.3.2.27) (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5) TRIM5 TRIM5 protein Tripartite motif containing 5 Trim5alpha |
Synonyms | TRIM5alpha RNF88 |
Description | FUNCTION: Capsid-specific restriction factor that prevents infection from non-host-adapted retroviruses. Blocks viral replication early in the life cycle, after viral entry but before reverse transcription. In addition to acting as a capsid-specific restriction factor, also acts as a pattern recognition receptor that activates innate immune signaling in response to the retroviral capsid lattice. Binding to the viral capsid triggers its E3 ubiquitin ligase activity, and in concert with the heterodimeric ubiquitin conjugating enzyme complex UBE2V1-UBE2N (also known as UBC13-UEV1A complex) generates 'Lys-63'-linked polyubiquitin chains, which in turn are catalysts in the autophosphorylation of the MAP3K7/TAK1 complex (includes TAK1, TAB2, and TAB3). Activation of the MAP3K7/TAK1 complex by autophosphorylation results in the induction and expression of NF-kappa-B and MAPK-responsive inflammatory genes, thereby leading to an innate immune response in the infected cell. Restricts infection by N-tropic murine leukemia virus (N-MLV), equine infectious anemia virus (EIAV), simian immunodeficiency virus of macaques (SIVmac), feline immunodeficiency virus (FIV), and bovine immunodeficiency virus (BIV) . Plays a role in regulating autophagy through activation of autophagy regulator BECN1 by causing its dissociation from its inhibitors BCL2 and TAB2 . Also plays a role in autophagy by acting as a selective autophagy receptor which recognizes and targets HIV-1 capsid protein p24 for autophagic destruction . . |
Accessions | D8L1Z7 ENST00000380034.8 [Q9C035-1] C9JWN8 L7REZ6 ENST00000419850.1 Q9C035 ENST00000396847.7 [Q9C035-3] H7C134 A0A804HHS7 D8L200 D8L1Z9 ENST00000682968.1 ENST00000438025.5 ENST00000380027.5 [Q9C035-4] E7EQQ5 ENST00000433961.5 [Q9C035-5] L7RET5 D8L1Z8 ENST00000412903.1 D8L203 Q05CU3 D8L201 ENST00000684655.1 [Q9C035-1] B1Q3L0 D8L202 |